✦ LIBER ✦

A dose-ranging, placebo-controlled, randomized clinical trial of alosetron, a 5-HT3 receptor antagonist, in the treatment of functional (nonulcer) dyspepsia

✍ Scribed by George E Dukes; Nicolas J Talley; Sander V van Zanten; Mark Heath; Susan C Sorrells; Teresa B Perschy; Christy Kleoudis; Allen W Mangel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized placebo-controlled trial of

✍ Blanca C. de Guia 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 108 KB

P.8.a.005 The effect of ondansetron, a 5

✍ G.K.H. The; G. Bleijenberg; J.K. Buitelaar; J.W.M. Van der Meer 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

A placebo-controlled trial of the 5-HT1A

✍ J. Tack; B. Van Den Elzen; G. Tytgat; E. Wajs; L. Van Nueten; F. De Ridder; G. B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 633 KB

An oxytocin receptor antagonist (atosiba

✍ Roberto Romero; Baha M. Sibai; Luis Sanchez-Ramos; Guillermo J. Valenzuela; Jean 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Treatment of Edema and Increased Capilla

✍ Cesarone, M. R.; Incandela, L.; DeSanctis, M. T.; Belcaro, G.; Griffin, M.; Ippo 📂 Article 📅 2002 🏛 SAGE Publications 🌐 English ⚖ 556 KB

229 - The efficacy of the NMDA receptor

✍ D. Pud; E. Eisenberg; A. Spitzer 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 254 KB